All treatments require evaluation and guidance from a licensed healthcare provider
Studies suggest that dysbiosis may affect the metabolism of dietary components, increase inflammation, and alter gut hormone signaling, leading to the development of obesity
Benefits may include: Significant appetite reduction Better HbA1c control Reduction in visceral fat Lower cardiovascular risk factors Sustainable weight management support However, results vary from patient to patient
Off-Label Weight Loss: Expanded Eligibility While Ozempic isnt FDA-approved specifically for weight loss, doctors frequently prescribe it off-label for weight management
Answer: Retatrutide trials focus on adults with obesity or overweight, typically a BMI at or above 27, who also carry a weight-related condition such as type 2 diabetes, pre-diabetes, high blood pressure, or high cholesterol